0001104659-24-010826.txt : 20240205
0001104659-24-010826.hdr.sgml : 20240205
20240205212302
ACCESSION NUMBER: 0001104659-24-010826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pichl Daniel
CENTRAL INDEX KEY: 0001819465
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 24597840
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC.
STREET 2: 100 WASHINGTON BLVD.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm245274-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-02
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001819465
Pichl Daniel
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief People Officer
1
Common Stock
2024-02-02
4
M
0
16250
27.64
A
71393
D
Common Stock
2024-02-02
4
S
0
9266
43.8098
D
62127
D
Common Stock
2024-02-02
4
S
0
14175
44.3144
D
47952
D
Common Stock
2024-02-02
4
S
0
1997
45.9471
D
45955
D
Common Stock
2024-02-02
4
S
0
743
46.4429
D
45212
D
Stock Option (Right to Buy)
27.64
2024-02-02
4
M
0
16250
0
D
2033-01-05
Common Stock
16250
48750
D
The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 9, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.045. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $44.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.31 to $47.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Twenty-five percent (25%) of this option shall vest and become exercisable on January 5, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person.
/s/ Francis I. Perier, Jr. as Attorney-in Fact
2024-02-05